Kanavos Unveils First Cannabis Knowledge Graph for Patients “`

b2f51cdad837c56cd44c68902e17f651 Kanavos Announces Industry First Knowledge Graph for Cannabis Patients

An AI-driven, scientifically validated system created in collaboration with Graphwise and HomeLab.

SAN FRANCISCO, Jan. 16, 2025JP Morgan Healthcare Conference Kanavos Inc., a leader in cannabinoid knowledge graph development, today announced a strategic partnership with Graphwise, a leading developer of advanced knowledge graph and semantic AI technologies. This collaboration, along with a partnership with HomeLab, California’s premier life sciences accelerator, represents a revolutionary approach to helping patients access evidence-based therapeutic treatments.

Utilizing Graphwise’s Semantic AI technology, Kanavos is building a comprehensive Knowledge Graph to offer patients interested in cannabis a central source for scientifically validated therapeutic treatments, facilitating personalized, actionable decisions. It uses AI, expert knowledge, and data to provide useful insights with context by analyzing relationships between words, unlike “generative AI,” which focuses on creating new content (text, images, or code) based on learned patterns.

“This partnership with Graphwise is a major step forward for patients seeking to use cannabinoids therapeutically,” says Dr. Deborah McGuinness, AAAI Fellow, Rensselaer Polytechnic Institute Professor, and Kavanos Chief Knowledge Officer. “Understanding cannabinoid research is challenging for patients and their healthcare teams.” By combining our expertise with Graphwise’s advanced technology, we empower individuals with the information to make informed decisions. This is crucial for offering personalized, evidence-based treatments and comparing therapeutic options.”

Advancing Cannabinoid-Based Medicine

Patients seeking information on cannabinoid therapies face considerable obstacles. The complexity of research, understanding different cannabinoids, and finding reliable information are significant hurdles.

Kanavos will create a comprehensive Knowledge Graph providing personalized, actionable insights from the latest scientific research. This innovative solution will leverage cannabinoid expertise, integrating data from clinical trials, preclinical research, and real-world evidence to provide the most current information. The HomeLab partnership will provide access to a network of innovators, speeding up the development and validation of these solutions.

“HomeLab is excited to support this groundbreaking collaboration between Kanavos and Graphwise,” says Julio de Unamuno IV, Executive Director of HomeLab at the Center for Novel Therapeutics at UC San Diego’s Science Research Park. “This aligns perfectly with our mission to foster innovation in life sciences. By supporting cutting-edge research and solutions like the Kanavos Knowledge Graph, we empower innovators to improve healthcare. This partnership shows the power of collaboration in life sciences, and we are excited about its impact on cannabinoid-based medicine.”

About the Collaboration

This initiative addresses crucial issues in the cannabis industry, including fragmented data and a lack of personalized recommendations. By combining scientific research, clinical data, and patient outcomes, Kanavos’ Cannabis Knowledge Graph, powered by Graphwise, will become a key resource for cannabinoid treatments. This comprehensive tool will help healthcare providers and patients make informed choices, improving patient care and driving innovation.

“We are thrilled to partner with Kanavos to apply knowledge graphs and AI to cannabinoid therapeutics,” says Antanas Kiryakov, President of Graphwise. “Connecting various data sources—from clinical trials to real-world evidence—unlocks valuable insights and empowers patients. This collaboration demonstrates how advanced AI and knowledge graphs can revolutionize healthcare and improve outcomes.”

About Graphwise

Graphwise helps organizations achieve ROI for enterprise AI by providing the most comprehensive knowledge graph and semantic AI solution. Graphwise is the result of a merger between Ontotext and Semantic Web Company. To learn more, visit  or follow us on LinkedIn.

About Kanavos

Kanavos is transforming cannabinoid-based medicine by building the world’s first comprehensive Cannabis Knowledge Graph, providing patients, researchers, and healthcare providers with a single source for scientifically validated therapeutic treatments that enable personalized, actionable decisions. Visit

About HomeLab Powered by LabFellows

HomeLab at the Center for Novel Therapeutics within UC San Diego’s Science Research Park. HomeLab, California’s award-winning life sciences accelerator focuses on translating innovations in areas such as cell and gene therapies and AI-driven drug discovery. HomeLab has helped 52 biotech startups raise over $1.5B since 2019. Learn more at.

Contact Information
Steve Bastasini
CEO – Kanavos
415-740-5528

SOURCE Kanavos

elong